{
    "2018-03-19": [
        [
            {
                "time": "2018-03-05",
                "original_text": "Ex-Chairman's Leveraged Buyout Bid a Real Long Shot",
                "features": {
                    "keywords": [
                        "Qualcomm",
                        "Leveraged",
                        "Buyout",
                        "Bid",
                        "Long",
                        "Shot"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-15",
                "original_text": "GlaxoSmithKline’s Valuation in March 2018",
                "features": {
                    "keywords": [
                        "GlaxoSmithKline",
                        "Valuation",
                        "March",
                        "2018"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-20",
                "original_text": "Radius Health Announces Positive Data on Lead Drug Tymlos",
                "features": {
                    "keywords": [
                        "Radius",
                        "Health",
                        "Positive",
                        "Data",
                        "Lead",
                        "Drug",
                        "Tymlos"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-25",
                "original_text": "Notable ETF Inflow Detected - XLV, PFE, TMO, LLY",
                "features": {
                    "keywords": [
                        "ETF",
                        "Inflow",
                        "XLV",
                        "PFE",
                        "TMO",
                        "LLY"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-30",
                "original_text": "Reading Merck’s Animal Health in 2017: A Post-4Q17 Update",
                "features": {
                    "keywords": [
                        "Merck",
                        "Animal",
                        "Health",
                        "2017",
                        "Post-4Q17",
                        "Update"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-05",
                "original_text": "See what the IHS Markit Score report has to say about Eli Lilly And Co.",
                "features": {
                    "keywords": [
                        "IHS",
                        "Markit",
                        "Score",
                        "report",
                        "Eli",
                        "Lilly",
                        "Co."
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}